TIFFANY GARTRELL: Open Payments
NPI 1962791491 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 7 payments from 5 companies in 2025. Trend: 2023 $163 · 2024 $74 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $66 |
| ABBVIE INC. | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: INGREZZA, VRAYLAR, COBENFY, UZEDY, INVEGA SUSTENNA.
Industry payments across GA — which companies pay providers there.
